Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 3
2012 1
2013 1
2014 3
2015 7
2016 11
2017 8
2018 9
2019 9
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes.
Kortüm KM, Mai EK, Hanafiah NH, Shi CX, Zhu YX, Bruins L, Barrio S, Jedlowski P, Merz M, Xu J, Stewart RA, Andrulis M, Jauch A, Hillengass J, Goldschmidt H, Bergsagel PL, Braggio E, Stewart AK, Raab MS. Kortüm KM, et al. Among authors: Merz M. Blood. 2016 Sep 1;128(9):1226-33. doi: 10.1182/blood-2016-02-698092. Epub 2016 Jul 25. Blood. 2016. PMID: 27458004 Free PMC article. Clinical Trial.
Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century.
Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H; GEKID Cancer Survival Working Group. Weberpals J, et al. Among authors: Merz M. Haematologica. 2017 Jun;102(6):e229-e232. doi: 10.3324/haematol.2016.157768. Epub 2017 Mar 9. Haematologica. 2017. PMID: 28280077 Free PMC article. No abstract available.
Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance.
Merz M, Hielscher T, Hoffmann K, Seckinger A, Hose D, Raab MS, Hillengass J, Jauch A, Goldschmidt H. Merz M, et al. Leukemia. 2018 Dec;32(12):2717-2719. doi: 10.1038/s41375-018-0202-1. Epub 2018 Jul 6. Leukemia. 2018. PMID: 29977018 No abstract available.
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels.
Yadav P, Merz M, Mai EK, Försti A, Jauch A, Goldschmidt H, Hemminki K. Yadav P, et al. Among authors: Merz M. Haematologica. 2018 Apr;103(4):e162-e164. doi: 10.3324/haematol.2017.184226. Epub 2018 Feb 1. Haematologica. 2018. PMID: 29419430 Free PMC article. No abstract available.
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma.
Merz M, Jauch A, Hielscher T, Bochtler T, Schönland SO, Seckinger A, Hose D, Bertsch U, Neben K, Raab MS, Hillengass J, Salwender H, Blau IW, Lindemann HW, Schmidt-Wolf IGH, Scheid C, Haenel M, Weisel KC, Goldschmidt H. Merz M, et al. Blood Adv. 2018 Jan 9;2(1):1-9. doi: 10.1182/bloodadvances.2017013334. Blood Adv. 2018. PMID: 31248901 Clinical Trial.
Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.
Merz M, Salwender H, Haenel M, Mai EK, Bertsch U, Kunz C, Hielscher T, Blau IW, Scheid C, Hose D, Seckinger A, Jauch A, Hillengass J, Raab MS, Schurich B, Munder M, Brossart P, Gerecke C, Lindemann HW, Zeis M, Weisel K, Duerig J, Goldschmidt H. Merz M, et al. Haematologica. 2016 Dec;101(12):e485-e487. doi: 10.3324/haematol.2016.151266. Epub 2016 Aug 18. Haematologica. 2016. PMID: 27540135 Free PMC article. Clinical Trial. No abstract available.
50 results
Jump to page
Feedback